title: Endoscopic inferior turbinate reduction: an outcomes analysis.
abstract: OBJECTIVE
  In a previous publication, we introduced an endoscopic technique for the treatment of nasal obstruction caused by inferior turbinate hypertrophy. The technique, a modification of the procedure popularized by Mabry, involves resecting the inferior and lateral aspects of the inferior turbinate with a microdebrider under endoscopic guidance. Our preliminary postoperative results were favorable. All 20 patients experienced improvement by postoperative day 5 and the incidence of complications over the first 6 months after surgery was low. The objective of this study is to perform a long-term outcomes analysis of patients undergoing the procedure.
  
  
  METHODS
  Follow-up survey questionnaire and analysis.
  
  
  METHODS
  We sent questionnaires to 60 patients, ranging from 6 to 40 months after surgery, inquiring about continued use of nasal medications, need for further surgery, presence of adverse effects, and improvement in symptoms. Nasal airway obstruction was assessed on a subjective scoring scale from 1 (no obstruction) to 6 (complete obstruction).
  
  
  RESULTS
  Of the 28 (47%) patients who returned questionnaires, the severity of daytime nasal obstruction was rated as 2.3 and nighttime nasal obstruction as 2.7. The use of nasal steroids and oral decongestants was 25% and 21%, respectively. Adverse effects were minimal and all but one patient (96%) experienced improvement in their nasal airway.
  
  
  CONCLUSIONS
  These results confirm the long-term effectiveness of this procedure for the relief of nasal obstruction.
authors.affiliation: Division of Otolaryngology-Head and Neck Surgery, George Washington University, Washington, DC, USA.
authors.forename: A
authors.initials: A
authors.lastname: Gupta
authors.forename: E
authors.initials: E
authors.lastname: Mercurio
authors.forename: S
authors.initials: S
authors.lastname: Bielamowicz
mesh_terms: D004724:Endoscopy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006984:Hypertrophy; D008297:Male; D014663:Nasal Decongestants / Q000627:therapeutic use; D015508:Nasal Obstruction / Q000209:etiology / Q000601:surgery*; D009300:Nasal Septum / Q000601:surgery; D017063:Outcome Assessment, Health Care; D017060:Patient Satisfaction; D011795:Surveys and Questionnaires; D013997:Time Factors; D014420:Turbinates / Q000473:pathology / Q000601:surgery*
chemical_list: D014663:Nasal Decongestants